Navigation Links
Insulin-Linked Hormone May Also Raise Alzheimer's Risk
Date:1/3/2012

TUESDAY, Jan. 3 (HealthDay News) -- Rising levels of a hormone associated with sensitizing the body to insulin appears to raise the risk for developing dementia and Alzheimer's among women, new research reveals.

The hormone in question, adiponectin, is derived from visceral fat. It is known to play a role in regulating the metabolism of glucose and lipids, while also carrying certain anti-inflammatory characteristics.

So, the finding is therefore somewhat unexpected, given that insulin resistance and inflammation are considered to be hallmarks of both type 2 diabetes and Alzheimer's disease (AD). The logical presumption would have been that anything that lowers insulin resistance and inflammation might also reduce the risk for dementia.

Study leader Thomas van Himbergen, of the Lipid Metabolism Laboratory with the Human Nutrition Research Center on Aging at Tufts University in Boston, and his colleagues report their finding online Jan. 2 in the Archives of Neurology.

"It is well established that insulin signaling is dysfunctional in the brains of patients with AD, and since adiponectin enhances insulin sensitivity, one would also expect beneficial actions protecting against cognitive decline," van Himbergen said in a journal news release. "Our data, however, indicate that elevated adiponectin level was associated with an increased risk of dementia and AD in women."

The authors note that the global incidence of dementia is projected to double over the next two decades, at which point it will affect roughly 72 million people.

To get at possible mechanism and indicators of the onset of Alzheimer's, the team took blood samples from 541 women over the course of 13 years. The samples were measured for levels of a number of markers, including glucose, insulin and adiponectin. All patients were simultaneously monitored for dementia symptoms.

During the study, 159 patients went on to develop dementia, of which 125 were Alzheimer's cases.

In the end, the investigators concluded that only a rise in adiponectin signaled an increased risk for both all-cause dementia and/or Alzheimer's.

More information

For more on dementia, visit the Alzheimer's Association.

-- Alan Mozes

SOURCE: Archives of Neurology, news release, Jan. 2, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pioneering Hormone Therapist to Host Free Health Seminar
2. Hormone May Prevent Aggressive Breast Cancer
3. Bonding Hormone Might Help Some With Autism
4. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
5. Early On, Hormone Therapy May Raise Womens Heart Risks
6. Testicular Cancer Survivors May Have Hormone Deficiency
7. Stress hormone, depression trigger obesity in girls
8. Buy HGH Website Educates Consumers on the Pros and Cons of Human Growth Hormone Supplements
9. Hormone thought to slow aging associated with increased risk of cancer death
10. Hormone Outperforms Insulin in Diabetic Mice
11. High Hormone Level Linked to Cancer Death in Older Men
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Insulin-Linked Hormone May Also Raise Alzheimer's Risk 
(Date:12/5/2016)... ... December 05, 2016 , ... Sideline Products is a Southern York County ... the smaller rider and the horse. Smaller saddles can pinch and irritate the horse ... fit over a properly fitted western saddle so it does not impact the comfort ...
(Date:12/5/2016)... ... ... “Life Will Never Be The Same” is a fictional tale about growing up with ... is the creation of published author, Kim T. Briggs, a self-described “big kid” who ... religion and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama ...
(Date:12/5/2016)... ... , ... Sabah Shah MD, MBA has joined the Retina Group of New York ... by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care ... of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. ...
(Date:12/5/2016)... Greifensee, Switzerland (PRWEB) , ... ... ... testing between professional calibrations is an excellent way to ensure moisture measurements ... methods are time-consuming and impractical. , Now, METTLER TOLEDO offers a ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... December 5, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... developing promising therapeutic candidates, presents positive Phase 2a correlative data, ... leading oncology platform at the ongoing 58th American Society of ... Diego, California . ... , , As ...
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: